Multiple Myeloma and Other Monoclonal Gammopathies for Non-Haematologists
Format
In-Person
Starting date
June
26
Duration
11 hours
ECTS
1
Max. participants
35
Tuition fee
600€
About the course
Monoclonal gammopathies (MG) are highly prevalent haematological disorders that can lead to severe disease. As an age-associated disorder, and due to the easy access to diagnostic tests, the number of cases is expected to increase.
The current clinical tools allow for a very accurate assessment of prognosis, which may guide the best approach to each patient. As such, this course aims to provide a clear vision on how generalist physicians may provide the best guidance to a suspected MG, how clinical findings should be interpreted, which tests provide the most information, when to refer to a specialist and how to complement the specialist’s follow-up.
The current clinical tools allow for a very accurate assessment of prognosis, which may guide the best approach to each patient. As such, this course aims to provide a clear vision on how generalist physicians may provide the best guidance to a suspected MG, how clinical findings should be interpreted, which tests provide the most information, when to refer to a specialist and how to complement the specialist’s follow-up.
Prevalence and Clinical Relevance
Monoclonal gammopathies are common age-related blood disorders that may progress to serious disease, with increasing diagnosis due to improved testing
Prognosis and Risk Stratification
Modern clinical tools enable accurate risk assessment and prognosis, helping guide individualized patient management
Clinical Approach and Referral Pathways
The course focuses on supporting general physicians in diagnosis, interpretation of results, appropriate testing, referral decisions, and collaboration with specialists
